Ruby Dhar

1.3k total citations
62 papers, 704 citations indexed

About

Ruby Dhar is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Ruby Dhar has authored 62 papers receiving a total of 704 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 12 papers in Immunology and 10 papers in Oncology. Recurrent topics in Ruby Dhar's work include Reproductive System and Pregnancy (8 papers), Pregnancy and preeclampsia studies (7 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Ruby Dhar is often cited by papers focused on Reproductive System and Pregnancy (8 papers), Pregnancy and preeclampsia studies (7 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Ruby Dhar collaborates with scholars based in India, United States and Saudi Arabia. Ruby Dhar's co-authors include Subhradip Karmakar, Chandana Das, Karthikeyan Pethusamy, Sunil Singh, Babban Jee, Indranil Chattopadhyay, Indrani Mukherjee, Kevin P. White, Caleb B. Kallen and Jyoti Sharma and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Ruby Dhar

55 papers receiving 697 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruby Dhar India 13 369 138 131 89 88 62 704
Subhradip Karmakar India 17 404 1.1× 204 1.5× 207 1.6× 112 1.3× 103 1.2× 77 894
Charlotte Gustafsson Sweden 12 283 0.8× 432 3.1× 165 1.3× 51 0.6× 55 0.6× 20 778
Susann Busch Sweden 12 371 1.0× 275 2.0× 81 0.6× 148 1.7× 171 1.9× 15 716
Shangwei Li China 14 183 0.5× 210 1.5× 72 0.5× 69 0.8× 39 0.4× 29 488
Twanda L. Thirkill United States 19 341 0.9× 231 1.7× 240 1.8× 35 0.4× 43 0.5× 32 810
Yanwu Zeng China 12 489 1.3× 45 0.3× 61 0.5× 85 1.0× 133 1.5× 32 827
Kumarasamypet M. Mohankumar India 14 378 1.0× 233 1.7× 29 0.2× 135 1.5× 164 1.9× 27 827
Mallikarjun Bidarimath Canada 13 257 0.7× 371 2.7× 241 1.8× 169 1.9× 37 0.4× 20 664
Jean‐Luc Servely France 15 350 0.9× 99 0.7× 39 0.3× 94 1.1× 168 1.9× 26 768
Cheng Lu China 21 659 1.8× 137 1.0× 123 0.9× 381 4.3× 238 2.7× 58 1.2k

Countries citing papers authored by Ruby Dhar

Since Specialization
Citations

This map shows the geographic impact of Ruby Dhar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruby Dhar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruby Dhar more than expected).

Fields of papers citing papers by Ruby Dhar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruby Dhar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruby Dhar. The network helps show where Ruby Dhar may publish in the future.

Co-authorship network of co-authors of Ruby Dhar

This figure shows the co-authorship network connecting the top 25 collaborators of Ruby Dhar. A scholar is included among the top collaborators of Ruby Dhar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruby Dhar. Ruby Dhar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Singh, Gurpreet, et al.. (2025). Next-Generation models of Gallbladder Carcinoma: Linking biological insights to precision medicine. Critical Reviews in Oncology/Hematology. 214. 104827–104827.
2.
Dhar, Ruby, et al.. (2025). Human metapneumovirus. Asian Journal of Medical Sciences. 16(3). 142–146. 1 indexed citations
3.
Gogoi, Gayatri, et al.. (2025). Investigating the interaction of ACKR1 and c-Myc in the breast carcinoma tumor microenvironment modulation. Discover Oncology. 16(1). 1615–1615.
4.
Gogia, Ajay, et al.. (2025). Comprehensive Overview of Breast Cancer in India. JCO Global Oncology. 11(11). e2500083–e2500083. 1 indexed citations
5.
Bhaskar, Yogendra, et al.. (2025). Role of AI in empowering and redefining the oncology care landscape: perspective from a developing nation. Frontiers in Digital Health. 7. 1550407–1550407. 5 indexed citations
6.
Shankar, Abhishek, et al.. (2024). Applications of Quantum Dots in Preventive Oncology. Asian Pacific Journal of Cancer Prevention. 25(3). 747–756. 12 indexed citations
7.
Srivastava, Anurag, Rajinder Parshad, Sandeep Mathur, et al.. (2024). Prognostic role of Androgen Receptor splice variant 7 (AR-V7) in the pathogenesis of breast cancer. BMC Cancer. 24(1). 1398–1398. 6 indexed citations
8.
Dhar, Ruby, et al.. (2024). JN.1: The new COVID-19 variant of concern?. Asian Journal of Medical Sciences. 15(2). 251–253. 1 indexed citations
9.
Gül, Ahmet, et al.. (2024). Aberrant expression of solute carrier family transporters in placentas associated with pregnancy complications. Placenta. 159. 9–19. 1 indexed citations
10.
Gul, Ambreen, et al.. (2024). Role of next‐generation sequencing in revolutionizing healthcare for cancer management. SHILAP Revista de lepidopterología. 3(4). 5 indexed citations
11.
Dhar, Ruby, et al.. (2023). Illuminating oncology research by bioluminescent imaging. Asian Journal of Medical Sciences. 14(11). 315–319. 2 indexed citations
12.
Mukherjee, Indrani, Subhrajit Biswas, Sunil Singh, et al.. (2023). Monosodium Glutamate Perturbs Human Trophoblast Invasion and Differentiation through a Reactive Oxygen Species-Mediated Pathway: An In-Vitro Assessment. Antioxidants. 12(3). 634–634. 5 indexed citations
13.
Dhar, Ruby, Arun Kumar, & Subhradip Karmakar. (2023). Smart wearable devices for real-time health monitoring. SHILAP Revista de lepidopterología. 14(12). 1–3. 2 indexed citations
14.
Pethusamy, Karthikeyan, Gaurav Kumar, Manoranjan Mahapatra, et al.. (2023). Alterations of the expression of TET2 and DNA 5-hmC predict poor prognosis in Myelodysplastic Neoplasms. BMC Cancer. 23(1). 1035–1035. 3 indexed citations
15.
Dhar, Ruby, et al.. (2022). Fenofibrate mediated activation of PPARα negatively regulates trophoblast invasion. Placenta. 126. 140–149. 3 indexed citations
16.
Dhar, Ruby, Shweta Rana, J. B. Sharma, et al.. (2022). India’s Opportunities and Challenges in Establishing a Twin Registry: An Unexplored Human Resource for the World’s Second-Most Populous Nation. Twin Research and Human Genetics. 25(3). 156–164. 1 indexed citations
17.
Singh, Sunil, Indrani Mukherjee, Karthikeyan Pethusamy, et al.. (2020). Potential SARS-CoV-2 interactions with proteins involved in trophoblast functions – An in-silico study. Placenta. 103. 141–151. 25 indexed citations
18.
Dhar, Ruby. (2020). MTiness in pseudo-malignant behavior of trophoblasts during embryo implantation. Frontiers in bioscience. 26(4). 717–743. 5 indexed citations
19.
Dhar, Ruby, Karthikeyan Pethusamy, Sunil Kumar Singh, et al.. (2019). Draft genome of Ompok bimaculatus (Pabda fish). BMC Research Notes. 12(1). 825–825. 7 indexed citations
20.
Dhar, Ruby, et al.. (2002). Steroids Modulate the Expression of α4 Integrin in Mouse Blastocysts and Uterus During Implantation1. Biology of Reproduction. 66(6). 1784–1789. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026